Voyageur Pharmaceuticals Ltd. (VYYRF)

Compare

0.0020

0.0000

(0.00%)

As of December 16 at 3:00:00 PM EST. Market Open.

Top TSX Penny Stocks To Watch In December 2024

The Canadian market has been experiencing a dynamic period, with investors closely monitoring economic trends and portfolio strategies to align with their long-term financial goals. For those interested in smaller or newer companies, penny stocks—despite the term's somewhat outdated connotation—remain relevant as an investment area offering potential value. This article will explore several penny stocks that stand out for their financial strength, making them intriguing options for investors...

Simply Wall St. 18 hours ago

VYYRF
0.00%
EMUSF

STXPF
CMC Metals And 2 Other TSX Penny Stocks With Promising Prospects

The Canadian market has been experiencing significant shifts following the decisive U.S. election outcome, which alleviated some uncertainties and led to a notable post-election rally. In light of these changes, investors are increasingly focusing on long-term fundamentals and opportunities within various sectors. Penny stocks, while an older term, continue to represent intriguing prospects for those interested in smaller or newer companies with potential growth opportunities at lower price...

Simply Wall St. last month

ROMJF

VYYRF
0.00%
CMCXF
Voyageur Announces Proposed Private Placement

Calgary, Alberta--(Newsfile Corp. - October 17, 2024) - Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) ("Voyageur" or the "Corporation"), is pleased to announce a proposed non-brokered private placement of up to 16,666,667 units ("Units") at a price of $0.06 per Unit, for gross proceeds of up to CND$1,000,000 (the "Offering"). There is no minimum Offering. Each Unit shall be comprised of one common share in the capital of the Corporation (each, a "Common ...

Newsfile last month

VYYRF
0.00%
Voyageur Pharmaceuticals Grants Stock Options

Calgary, Alberta--(Newsfile Corp. - September 25, 2024) - Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) ("Voyageur" or the "Company") announces that it has granted an aggregate of 600,000 stock options (the "Options") to officers of the Company pursuant to its incentive stock option plan. The Options were granted at an exercise price of $0.06 per share, vest immediately, and have a 10-year term. The Options are subject to regulatory and TSX Venture Exchange ...

Newsfile 2 months ago

VYYRF
0.00%
Update - Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium Contrast

CALGARY, Canada - (NewMediaWire) - May 28, 2024 - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Company") proudly announces its first international distribution agreement with a sales commitment of USD $1.9 million (CAD $...

NewMediaWire 6 months ago

VYYRF
0.00%
Voyageur Pharmaceuticals Ltd Signs Radiology Drug Sales Contract Valued at $USD 1.9 Million for SmoothX 2% Barium Contrast

CALGARY, Canada - (NewMediaWire) - May 27, 2024 - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Company") proudly announces signing its first sales contract valued at USD $1.9 million (approximately CAD $2.6). The contrac...

NewMediaWire 6 months ago

VYYRF
0.00%

Performance Overview

Return	VYYRF	S&P/TSX Composite index
YTD	-95.00%	+19.65%
1-Year	-93.98%	+22.15%
3-Year	-97.15%	+20.91%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Voyageur Pharmaceuticals Ltd. (VYYRF)

Top TSX Penny Stocks To Watch In December 2024

CMC Metals And 2 Other TSX Penny Stocks With Promising Prospects

Voyageur Announces Proposed Private Placement

Voyageur Pharmaceuticals Grants Stock Options

Update - Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium Contrast

Voyageur Pharmaceuticals Ltd Signs Radiology Drug Sales Contract Valued at $USD 1.9 Million for SmoothX 2% Barium Contrast

Performance Overview